{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:18:11Z","timestamp":1772752691240,"version":"3.50.1"},"publisher-location":"Boston, MA","reference-count":134,"publisher":"Springer US","isbn-type":[{"value":"9781461354611","type":"print"},{"value":"9781461512493","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001]]},"DOI":"10.1007\/978-1-4615-1249-3_19","type":"book-chapter","created":{"date-parts":[[2011,5,4]],"date-time":"2011-05-04T16:39:50Z","timestamp":1304527190000},"page":"229-251","source":"Crossref","is-referenced-by-count":25,"title":["Mitochondrial Dysfunction in Neurodegenerative Disorders and Ageing"],"prefix":"10.1007","author":[{"given":"Christopher","family":"Turner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony H. V.","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0074-7696(08)62068-9","volume":"41","author":"MW Gray","year":"1992","unstructured":"Gray MW (1992) The endosymbiont hypothesis revisited. Int Rev Cytol 41: 233\u2013357.","journal-title":"Int Rev Cytol"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-291X(69)90633-0","volume":"34","author":"JB Galper","year":"1969","unstructured":"Galper JB, Darnell JE (1969) The presence of N-formyl-methionyl-tRNA in HeLa cell mitochondria. Biochem Biophys Res Commun 34: 205\u2013214.","journal-title":"Biochem Biophys Res Commun"},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1021\/bi00820a011","volume":"9","author":"JL Epler","year":"1970","unstructured":"Epler JL, Shugart LR, Barnett WE (1970) N-formylmethionyl transfer ribonucleic acid in mitochondria from Neurospora. Biochemistry 9: 3575\u20133579.","journal-title":"Biochemistry"},{"key":"19_CR4","volume-title":"Mitochondriaand free radicals in neurodegenerative diseases","author":"MF Beal","year":"1997","unstructured":"Beal MF, Howell N, Bodis-Wollner I (1997) Mitochondria and free radicals in neurodegenerative diseases. Wiley-Liss, New York."},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/290457a0","volume":"290","author":"S Anderson","year":"1981","unstructured":"Anderson S, Bankier AT, Barrell BG et al. (1981) Sequence and organisation of the human mitochondrial genome. Nature 290: 457\u2013465.","journal-title":"Nature"},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0167-4889(99)00128-7","volume":"1410","author":"JW Taanman","year":"1999","unstructured":"Taanman JW (1999) The human mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1410: 103\u2013123.","journal-title":"Biochim Biophys Acta"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.36.7.505","volume":"36","author":"F Chinnery","year":"1999","unstructured":"Chinnery F, Howell N, Andrews RA (1999) Clinical mitochondrial genetics. J Med Genet 36: 425\u2013436.","journal-title":"J Med Genet"},{"key":"19_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0168-9525(97)01266-3","volume":"13","author":"RN Lightowlers","year":"1997","unstructured":"Lightowlers RN, Chinnery PF, Turnbull DM et al. (1997) Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 13: 450\u2013455.","journal-title":"Trends Genet"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(99)05225-3","volume":"355","author":"JV Leonard","year":"2000","unstructured":"Leonard JV, Schapira AHV (2000) Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355: 299\u2013304.","journal-title":"Lancet"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0140-6736(99)05226-5","volume":"355","author":"JV Leonard","year":"2000","unstructured":"Leonard JV, Schapira AHV (2000) Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet 355: 389\u2013394.","journal-title":"Lancet"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"1","author":"Schapira Ally","year":"1989","unstructured":"Schapira Ally, Cooper JM, Dexter D et al. (1989) Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet 1: 1269.","journal-title":"Lancet"},{"key":"19_CR12","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","volume":"55","author":"AHV Schapira","year":"1990","unstructured":"Schapira AHV, Mann VM, Cooper JM et al. (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson\u2019s disease. J Neurochem 55: 2142\u20132145.","journal-title":"J Neurochem"},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/mds.870120323","volume":"12","author":"M Gu","year":"1997","unstructured":"Gu M, Gash MT, Cooper JM et al. (1997) Mitochondrial respiratory chain function in multiple system atrophy. Mov Disord 12: 418\u2013422.","journal-title":"Mov Disord"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0022-510X(98)00095-1","volume":"158","author":"M Gu","year":"1998","unstructured":"Gu M, Owen AD, Toffa SEK et al. (1998) Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J Neurol Sci 158: 24\u201329.","journal-title":"J Neurol Sci"},{"key":"19_CR15","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1212\/WNL.43.11.2170","volume":"43","author":"S DiMauro","year":"1993","unstructured":"DiMauro S (1993) Mitochondrial involvement in Parkinson\u2019s disease: the controversy continues. Neurology 43: 2170\u20132172.","journal-title":"Neurology"},{"key":"19_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0022-510X(94)90245-3","volume":"125","author":"DJ Taylor","year":"1994","unstructured":"Taylor DJ, Krige D, Barnes PRJ et al. (1994) A31P magnetic resonance spectroscopy study of mitochondria] function in skeletal muscle of patients with Parkinson\u2019s disease. J Neurol Sci 125: 77\u201381.","journal-title":"J Neurol Sci"},{"key":"19_CR17","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1212\/WNL.45.11.2097","volume":"45","author":"AMW Penn","year":"1995","unstructured":"Penn AMW, Roberts T, Hodder J etal. (1995) Generalised mitochondrial dysfunction in Parkinson\u2019s disease detected by magnetic resonance spectroscopy of muscle. Neurology 45: 2097\u20132099.","journal-title":"Neurology"},{"key":"19_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/mds.870090202","volume":"9","author":"AHV Schapira","year":"1994","unstructured":"Schapira AHV (1994) Evidence for mitochondrial dysfunction in Parkinson\u2019s disease - a critical appraisal. Mov Disord 9: 125\u2013138.","journal-title":"Mov Disord"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ana.410440207","volume":"44","author":"M Gu","year":"1998","unstructured":"Gu M, Cooper JM, Taanman JW et al. (1998) Mitochondrial DNA transmission of the mitochondria) defect of Parkinson\u2019s disease. Ann Neurol 44: 177\u2013186.","journal-title":"Ann Neurol"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/ana.410400417","volume":"40","author":"RH Swerdlow","year":"1996","unstructured":"Swerdlow RH, Parks JK, Miller SW et al. (1996) Origin and functional consequences of the complex I defect in Parkinson\u2019s disease. Ann Neurol 40: 663\u2013671.","journal-title":"Ann Neurol"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"GC Davis","year":"1979","unstructured":"Davis GC, Williams AC, Markey SP et al. (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1: 249\u2013254.","journal-title":"Psychiatry Res"},{"key":"19_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/ana.410360513","volume":"36","author":"FJG Vingerhoets","year":"1994","unstructured":"Vingerhoets FJG, Snow BJ, Tetrud JJ et al. (1994) Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol 36: 765\u2013770.","journal-title":"Ann Neurol"},{"key":"19_CR23","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.1471-4159.1991.tb11409.x","volume":"56","author":"RR Ramsay","year":"1991","unstructured":"Ramsay RR, Krueger MJ, Youngster SK et al. (1991) Interaction of 1-methyl-4phenylpyridinium ion (MPP+) and its analogs with rotenone\/piericidin binding site of NADH dehydrogenase. J Neurochem 56: 1184\u20131190.","journal-title":"J Neurochem"},{"key":"19_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1471-4159.1992.tb09789.x","volume":"58","author":"MJW Cleeter","year":"1992","unstructured":"Cleeter MJW, Cooper JM, Schapira AHV (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem 58: 786\u2013789.","journal-title":"J Neurochem"},{"key":"19_CR25","first-page":"169","volume":"10","author":"JD Adams","year":"1989","unstructured":"Adams JD, Klaidman LK, Odunze IN (1989) Oxidative effects of MPTP in the midbrain. Res Commun Subst Abuse 10: 169\u2013180.","journal-title":"Res Commun Subst Abuse"},{"key":"19_CR26","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/0006-291X(90)90498-C","volume":"170","author":"E Hasegawa","year":"1990","unstructured":"Hasegawa E, Takeshige K, Oishi T et al. (1990) 1-methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170: 1049\u20131055.","journal-title":"Biochem Biophys Res Commun"},{"key":"19_CR27","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nm0996-1017","volume":"1021","author":"P Hantraye","year":"1996","unstructured":"Hantraye P, Brouillet E, Ferrante R et al. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Med 1017\u20131021.","journal-title":"Nature Med"},{"key":"19_CR28","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","volume":"93","author":"S Przedborski","year":"1996","unstructured":"Przedborski S, Jackson-Lewis V, Yokoyama R et al. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 93: 4565\u20134571.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR29","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1046\/j.1471-4159.1997.69041771.x","volume":"69","author":"DA Monte Di","year":"1997","unstructured":"Di Monte DA, Royland JE, Anderson A et al. (1997) Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity. J Neurochem 69: 1771\u20131773.","journal-title":"J Neurochem"},{"key":"19_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0378-4347(00)82857-1","volume":"491","author":"T Niwa","year":"1989","unstructured":"Niwa T, Takeda N, Sasaoka T et al. (1989) Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry. J Chromatogr 491: 397\u2013403.","journal-title":"J Chromatogr"},{"key":"19_CR31","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0006-291X(87)80075-X","volume":"144","author":"T Niwa","year":"1987","unstructured":"Niwa T, Takeda N, Kaneda N et al. (1987) Presence of tetrahydroisoquinoline and 2methyl-tetrahydroquinoline in parkinsonian and normal human brains. Biochem Biophys Res Commun 144: 1084\u20131089.","journal-title":"Biochem Biophys Res Commun"},{"key":"19_CR32","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/0006-291X(89)90850-4","volume":"162","author":"K Suzuki","year":"1989","unstructured":"Suzuki K, Mizuno Y, Yoshida M (1989) Selective inhibition of complex I of the brain electron transport system by tetrahydroisoquinoline. Biochem Biophys Res Commun 162: 1541\u20131545.","journal-title":"Biochem Biophys Res Commun"},{"key":"19_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group (HDCRG)","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (HDCRG) (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72: 971\u2013983.","journal-title":"Cell"},{"key":"19_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ et al. (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropath Exp Neurol 44: 559\u2013577.","journal-title":"J Neuropath Exp Neurol"},{"key":"19_CR35","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","volume":"43","author":"BG Jenkins","year":"1993","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF (1993) Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localised1H NMR spectroscopy. Neurology 43: 2689\u20132695.","journal-title":"Neurology"},{"key":"19_CR36","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/S0140-6736(94)92987-4","volume":"343","author":"CA Davie","year":"1994","unstructured":"Davie CA, Barker GC, Quinn N et al. (1994) Proton MRS in Huntington\u2019s disease. Lancet 343: 1580.","journal-title":"Lancet"},{"key":"19_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1212\/WNL.42.1.223","volume":"42","author":"WRW Martin","year":"1992","unstructured":"Martin WRW, Clark C, Ammann W etal. (1992) Cortical glucose metabolism in Huntington\u2019s disease. Neurology 42: 223\u2013229.","journal-title":"Neurology"},{"key":"19_CR38","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","volume":"50","author":"BG Jenkins","year":"1998","unstructured":"Jenkins BG, Rosas HD, Chen YCI et al. (1998)1H NMR spectroscopy studies of Huntington\u2019s disease. Correlations with CAG repeat numbers. Neurology 50: 1357\u20131365.","journal-title":"Neurology"},{"key":"19_CR39","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1212\/WNL.50.4.1033","volume":"50","author":"TQ Hoang","year":"1998","unstructured":"Hoang TQ, Blum S, Dubowitz DJ et al. (1998) Quantitative proton-decoupled 31P MRS and1H MRS in the evaluation of Huntington\u2019s and Parkinson\u2019s diseases. Neurology 50: 1033\u20131040.","journal-title":"Neurology"},{"key":"19_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.410410206","volume":"41","author":"WJ Koroshetz","year":"1997","unstructured":"Koroshetz WJ, Jenkins BG, Rosen BR et al. (1997) Energy metabolism defects in Huntington\u2019s disease and effects of coenzyme Q10.. Ann Neurol 41: 160\u2013165.","journal-title":"Ann Neurol"},{"key":"19_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM et al. (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39: 385\u2013389.","journal-title":"Ann Neurol"},{"key":"19_CR42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U et al. (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41: 646\u2013653.","journal-title":"Ann Neurol"},{"key":"19_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MWJ, Xuereb J et al. (1999) Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain. Ann Neurol 45: 25\u201332.","journal-title":"Ann Neurol"},{"key":"19_CR44","doi-asserted-by":"crossref","first-page":"29405","DOI":"10.1016\/S0021-9258(18)43893-8","volume":"269","author":"A Hausladen","year":"1994","unstructured":"Hausladen A, Fridovich I (1994) Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J Biol Chem 269: 29405\u201329408.","journal-title":"J Biol Chem"},{"key":"19_CR45","doi-asserted-by":"publisher","first-page":"12248","DOI":"10.1073\/pnas.91.25.12248","volume":"91","author":"PR Gardner","year":"1994","unstructured":"Gardner PR, Nguyen DH, White CW (1994) Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc Natl Acad Sci USA 91: 12248\u201312252.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0896-6273(00)80052-5","volume":"16","author":"M Patel","year":"1996","unstructured":"Patel M, Day BJ, Crapo JD et al. (1996) Requirement for superoxide in excitotoxic cell death. Neuron 16: 345\u2013355.","journal-title":"Neuron"},{"key":"19_CR47","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1212\/WNL.40.8.1231","volume":"40","author":"WD Parker","year":"1998","unstructured":"Parker WD, Boyson SJ, Luder AS et al. (1990). Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington\u2019s disease. Neurology 40: 1231\u20131234.","journal-title":"Neurology"},{"key":"19_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.410430321","volume":"43","author":"J Arenas","year":"1998","unstructured":"Arenas J, Campos Y, Ribacoba R et al. (1998) Complex I defect in muscle from patients with Huntington\u2019s disease. Ann Neurol 43: 397\u2013400.","journal-title":"Ann Neurol"},{"key":"19_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/ana.410410203","volume":"41","author":"AHV Schapira","year":"1997","unstructured":"Schapira AHV (1997) Mitochondrial function in Huntington\u2019s disease: clues for the pathogenesis and prospects for treatment. Ann Neurol 41: 141\u2013142.","journal-title":"Ann Neurol"},{"key":"19_CR50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0005-2728(98)00164-9","volume":"1210","author":"AHV Schapira","year":"1999","unstructured":"Schapira AHV (1999) Mitochondrial involvement in Parkinson\u2019s disease, Huntington\u2019s disease, hereditary spastic paraplegia, and Friedreich\u2019s ataxia. Biochim Biophys Acta 1210: 159\u2013170.","journal-title":"Biochim Biophys Acta"},{"key":"19_CR51","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG et al. (1993) Neurochemical and histological characterisation of striatal excitotoxic lesions produced by the mitochondria) toxin 3nitropropionic acid. J Neurosci 13: 4181\u20134192.","journal-title":"J Neurosci"},{"key":"19_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M et al. (1996) Exon I of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87: 493\u2013506.","journal-title":"Cell"},{"key":"19_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","volume":"47","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi SJ, Workman J. Hart P et al. (2000) Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse. Ann Neurol 47: 80\u201386.","journal-title":"Ann Neurol"},{"key":"19_CR54","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","volume":"95","author":"JHJ Cha","year":"1998","unstructured":"Cha JHJ, Kosinski CM, Kerner JA et al. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc Natl Acad Sci USA 95: 6480\u20136485.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR55","first-page":"972","volume":"24","author":"MS Levine","year":"1998","unstructured":"Levine MS, Chesselet MF, Koppel A et al. (1998) Enhanced sensitivity to glutamate receptor activation in mouse models of Huntington\u2019s disease. J Neurosci 24: 972.","journal-title":"J Neurosci"},{"key":"19_CR56","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1046\/j.1471-4159.1998.71062642.x","volume":"71","author":"M Bogdanov","year":"1998","unstructured":"Bogdanov M, Ferrante RJ, Kuemmerle S et al. (1998) Increased vulnerability to 3nitropropionic acid in an animal model of Huntington\u2019s disease. J Neurochem 71: 2642\u20132644.","journal-title":"J Neurochem"},{"key":"19_CR57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1086\/301930","volume":"63","author":"G Michele De","year":"1998","unstructured":"De Michele G, De Fusco M, Cavalcanti F et al. (1998) A new locus for autosomal recessive hereditary spastic paraplegia. Am J Hum Genet 63: 135\u2013139.","journal-title":"Am J Hum Genet"},{"key":"19_CR58","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"217","author":"V Campuzano","year":"1996","unstructured":"Campuzano V, Montermini L, Molto MD et al. (1996) Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 217: 1423\u20131427.","journal-title":"Science"},{"key":"19_CR59","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","volume":"6","author":"V Campuzano","year":"1997","unstructured":"Campuzano V, Montermini L, Lutz Y et al. (1997) Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 6: 1771\u20131780.","journal-title":"Hum Mol Genet"},{"key":"19_CR60","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng0897-345","volume":"16","author":"H Koutnikova","year":"1997","unstructured":"Koutnikova H, Campuzano V, Foury F et al. (1997) Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nature Genet 16: 345\u2013351.","journal-title":"Nature Genet"},{"key":"19_CR61","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/ana.410420222","volume":"42","author":"J Priller","year":"1997","unstructured":"Priller J, Scherzer CR, Faber PW et al. (1997) Frataxin gene of Friedreich\u2019s ataxia is targeted to mitochondria. Ann Neurol 42: 265\u2013269.","journal-title":"Ann Neurol"},{"key":"19_CR62","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng0897-352","volume":"16","author":"RB Wilson","year":"1997","unstructured":"Wilson RB, Roof DM (1997) Respiratory deficiency due to a loss of mitochondria) DNA in yeast lacking frataxin homologue. Nature Genet 16: 352\u2013357.","journal-title":"Nature Genet"},{"key":"19_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/BF00290133","volume":"246","author":"A Sanyal","year":"1995","unstructured":"Sanyal A, Harrington A, Herbert CJ et al. (1995) Heat shock protein HSP60 can alleviate the phenotype of mitochondrial RNA-deficient temperature-sensitive mna2 pet mutants. Mol Gen Genet 246: 56\u201364.","journal-title":"Mol Gen Genet"},{"key":"19_CR64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S0317167100025580","volume":"3","author":"G Sanchez-Casis","year":"1976","unstructured":"Sanchez-Casis G, Cote M, Barbeau A (1976) Pathology of the heart in Friedreich\u2019s ataxia. Can J Neurol Sci 3: 349\u2013354.","journal-title":"Can J Neurol Sci"},{"key":"19_CR65","first-page":"451","volume":"183","author":"PK Thomas","year":"1993","unstructured":"Thomas PK, Cooper JM, King RI IM et al. (1993) Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondria) function. J Anat 183: 451\u2013461.","journal-title":"J Anat"},{"key":"19_CR66","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1212\/WNL.38.8.1292","volume":"38","author":"G Finocchiaro","year":"1988","unstructured":"Finocchiaro G, Baio G, Micossi P et al. (1988) Glucose metabolism alterations in Friedreich\u2019s ataxia. Neurology 38: 1292\u20131296.","journal-title":"Neurology"},{"key":"19_CR67","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ng1097-215","volume":"17","author":"A Rotig","year":"1997","unstructured":"Rotig A, De Lonlay P, Cluetien D et al. (1997) Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich\u2019s ataxia. Nature Genet 17: 215\u2013217.","journal-title":"Nature Genet"},{"key":"19_CR68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","volume":"9","author":"JL Bradley","year":"2000","unstructured":"Bradley JL, Blake J, Chamberlain S et al. (2000) Clinical, biochemical and molecular genetic correlations in Friedreich\u2019s ataxia. Hum Mol Genet 9: 275\u2013282.","journal-title":"Hum Mol Genet"},{"key":"19_CR69","doi-asserted-by":"publisher","first-page":"11492","DOI":"10.1073\/pnas.96.20.11492","volume":"96","author":"R Lodi","year":"1999","unstructured":"Lodi R, Cooper JM, Bradley JL et al. (1999) Deficit of in vivo mitochondrial ATP production in patients with Friedreich\u2019s ataxia. Proc Natl Acad Sci USA 96: 11492\u201311495.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR70","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1056\/NEJM198604103141506","volume":"314","author":"R Katzman","year":"1986","unstructured":"Katzman R (1986) Alzheimer\u2019s disease. New Engl J Med 314: 457\u2013465.","journal-title":"New Engl J Med"},{"key":"19_CR71","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1212\/WNL.43.7.1377","volume":"43","author":"R Duara","year":"1993","unstructured":"Duara R, Lopez-Alberola RF, Barker WW et al. (1993) A comparison of familial and sporadic Alzheimer\u2019s disease. Neurology 43: 1377\u20131384.","journal-title":"Neurology"},{"key":"19_CR72","first-page":"36","volume":"5","author":"R Mielke","year":"1994","unstructured":"Mielke R, Herholz K, Grond M et al. (1994) Clinical deterioration in probable Alzheimer\u2019s disease correlates with progressive metabolic impairment of association areas. Dementia 5: 36\u201341.","journal-title":"Dementia"},{"key":"19_CR73","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0304-3940(85)90543-9","volume":"33","author":"RP Friedland","year":"1985","unstructured":"Friedland RP, Budinger TF, Koss E et al. (1985) Alzheimer\u2019s disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett 33: 235\u2013240.","journal-title":"Neurosci Lett"},{"key":"19_CR74","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1212\/WNL.44.6.1090","volume":"44","author":"WD Parker","year":"1994","unstructured":"Parker WD, Parks JK, Filley CM et al. (1994) Electron transport chain defects in Alzheimer\u2019s disease brain. Neurology 44: 1090\u20131096.","journal-title":"Neurology"},{"key":"19_CR75","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1212\/WNL.45.3.482","volume":"45","author":"WD Parker","year":"1995","unstructured":"Parker WD, Parks JK (1995) Cytochrome c oxidase in Alzheimer\u2019s disease brain: Neurology 45: 482\u2013486.","journal-title":"Neurology"},{"key":"19_CR76","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","volume":"59","author":"SJ Kish","year":"1992","unstructured":"Kish SJ, Bergeran C, Rajput A et al. (1992) Brain cytochrome oxidase in Alzheimer\u2019s disease. J Neurochem 59: 776\u2013779.","journal-title":"J Neurochem"},{"key":"19_CR77","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1046\/j.1471-4159.1994.63062179.x","volume":"63","author":"EM Mutisya","year":"1994","unstructured":"Mutisya EM, Bowling AC, Beal MF (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer\u2019s disease. J Neurochem 63: 2179\u20132184.","journal-title":"J Neurochem"},{"key":"19_CR78","first-page":"711","volume":"6","author":"P Chagnon","year":"1995","unstructured":"Chagnon P, Betard C, Robitaille Yet al. (1995) Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Mol Neurosci 6: 711\u2013715.","journal-title":"Mol Neurosci"},{"key":"19_CR79","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/00005072-199311000-00004","volume":"52","author":"NA Simonian","year":"1993","unstructured":"Simonian NA, Hyman BT (1993) Functional alterations in Alzheimer\u2019s disease: diminution of cytochrome oxidase in the hippocampal formation. J Neuropathol Exp Neurol 52: 580\u2013585.","journal-title":"J Neuropathol Exp Neurol"},{"key":"19_CR80","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/00005072-199409000-00010","volume":"53","author":"NA Simonian","year":"1994","unstructured":"Simonian NA, Hyman BT (1994) Functional alterations in Alzheimer\u2019s disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in hippocampal formation. J Neuropathol Exp Neurol 53: 508\u2013512.","journal-title":"J Neuropathol Exp Neurol"},{"key":"19_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0005-2728(98)00165-0","volume":"1410","author":"E Bonilla","year":"1999","unstructured":"Bonilla E, Tanji K, Hirano M et al. (1999) Mitochondrial involvement in Alzheimer\u2019s disease. Biochim Biophys Acta 1410: 171\u2013182.","journal-title":"Biochim Biophys Acta"},{"key":"19_CR82","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1523\/JNEUROSCI.13-05-01805.1993","volume":"13","author":"RF Hevner","year":"1993","unstructured":"Hevner RF, Wong-Riley MTT (1993) Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J Neurosci 13: 1805\u20131819.","journal-title":"J Neurosci"},{"key":"19_CR83","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1006\/geno.1994.1525","volume":"23","author":"M Corral-Debrinski","year":"1994","unstructured":"Corral-Debrinski M, Horton T, Lott MT et al. (1994) Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23: 471\u2013476.","journal-title":"Genomics"},{"key":"19_CR84","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/00001756-199306000-00051","volume":"4","author":"BJ Blanchard","year":"1993","unstructured":"Blanchard BJ, Park T, Fripp WJ et al. (1993) A mitochondrial DNA deletion in normally aging and Alzheimer brain tissue. Neuroreport 4: 799\u2013802.","journal-title":"Neuroreport"},{"key":"19_CR85","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1006\/exnr.1996.0180","volume":"142","author":"K Chandrasekaran","year":"1996","unstructured":"Chandrasekaran K, Hatanpaa K, Brady DR et al. (1996) Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer\u2019s disease. Exp Neurol 142: 80\u201388.","journal-title":"Exp Neurol"},{"key":"19_CR86","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1212\/WNL.47.1.254","volume":"47","author":"SD Edland","year":"1996","unstructured":"Edland SD, Silverman JM, Peskind ER et al. (1996) Increased risk of dementia in mothers of Alzheimer\u2019s disease cases:evidence for maternal inheritance. Neurology 47: 254\u2013256.","journal-title":"Neurology"},{"key":"19_CR87","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/geno.1993.1299","volume":"17","author":"JM Shoffner","year":"1993","unstructured":"Shoffner JM, Brown MD, Torroni A et al. (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson\u2019s disease patients. Genomics 17: 171\u2013184.","journal-title":"Genomics"},{"key":"19_CR88","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0304-3940(95)12146-3","volume":"201","author":"MA Wragg","year":"1995","unstructured":"Wragg MA, Talbot CJ, Morris JC et al. (1995) No association found between Alzheimer\u2019s disease and a mitochondrial tRNA glutamine gene variant. Neurosci Lett 201: 107\u2013110.","journal-title":"Neurosci Lett"},{"key":"19_CR89","doi-asserted-by":"publisher","first-page":"6892","DOI":"10.1073\/pnas.92.15.6892","volume":"92","author":"T Hutchin","year":"1995","unstructured":"Hutchin T, Cortopassi G (1995) A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci USA 92: 6892\u20136895.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR90","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1073\/pnas.94.9.4526","volume":"94","author":"RE Davis","year":"1997","unstructured":"Davis RE, Miller S, Herrnstadt C et al. (1997) Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci USA 94:4526\u20134531.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR91","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1212\/WNL.49.4.918","volume":"49","author":"RH Swerdlow","year":"1997","unstructured":"Swerdlow RH, Parks JK, Cassarino DS et al. (1997) Cybrids in Alzheimer\u2019s disease: a cellular model of disease? Neurology 49: 918\u2013925.","journal-title":"Neurology"},{"key":"19_CR92","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1212\/WNL.51.1.326","volume":"51","author":"EA Schon","year":"1998","unstructured":"Schon EA, Shoubridge EA, Moraes CT (1998) Cybrids in Alzheimer\u2019s disease: a cellular model of disease? Neurology 51: 326\u2013327.","journal-title":"Neurology"},{"key":"19_CR93","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"JT Coyle","year":"1993","unstructured":"Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262: 689\u2013695.","journal-title":"Science"},{"key":"19_CR94","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1046\/j.1471-4159.1995.65052146.x","volume":"65","author":"K Hensley","year":"1995","unstructured":"Hensley K, Hall N, Subramanian R et al. (1995) Brain regional correspondence between Alzheimer\u2019s disease histopathology and biomarkers of protein oxidation. J Neurochem 65: 2146\u20132156.","journal-title":"J Neurochem"},{"key":"19_CR95","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1212\/WNL.45.8.1594","volume":"45","author":"MA Lovell","year":"1995","unstructured":"Lovell MA, Ehman WD, Butler SM et al. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer\u2019s disease. Neurology 45: 1594\u20131601.","journal-title":"Neurology"},{"key":"19_CR96","first-page":"21","volume":"149","author":"PF Good","year":"1996","unstructured":"Good PF, Werner P, Hsu A et al. (1996) Evidence for neuronal oxidative damage in Alzheimer\u2019s disease. Am J Pathol 149: 21\u201328.","journal-title":"Am J Pathol"},{"key":"19_CR97","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/382120b0","volume":"382","author":"MA Smith","year":"1996","unstructured":"Smith MA, Perry G, Richey PL et al. (1996) Oxidative damage in Alzheimer\u2019s. Nature 382: 120\u2013121.","journal-title":"Nature"},{"key":"19_CR98","doi-asserted-by":"crossref","first-page":"21614","DOI":"10.1016\/S0021-9258(17)31849-5","volume":"269","author":"MD Ledesma","year":"1994","unstructured":"Ledesma MD, Boney P, Colaco C et al. (1994) Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 269: 21614\u201321619.","journal-title":"J Biol Chem"},{"key":"19_CR99","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","volume":"91","author":"MP Vitek","year":"1994","unstructured":"Vitek MP, Bhattacharya K, Glendening JM (1994) Advanced glycation end-products contribute to amyloidosis in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 91: 4766\u20134770.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR100","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1046\/j.1471-4159.1995.64031216.x","volume":"64","author":"W Gsell","year":"1995","unstructured":"Gsell W, Conrad R, Hickethier M et al. (1995) Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem 64: 1216\u20131223.","journal-title":"J Neurochem"},{"key":"19_CR101","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"RC Griggs","year":"1995","unstructured":"Griggs RC, Askanas V, DiMauro S et al. (1995) Inclusion body myositis and myopathies. Ann Neurol 38: 705\u2013713.","journal-title":"Ann Neurol"},{"key":"19_CR102","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ana.410340416","volume":"34","author":"P Mecocci","year":"1993","unstructured":"Mecocci P, MacGarvey U, Kaufman AE et al. (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 34: 609\u2013616.","journal-title":"Ann Neurol"},{"key":"19_CR103","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ana.410360510","volume":"36","author":"P Mecocci","year":"1994","unstructured":"Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer\u2019s disease. Ann Neurol 36: 747\u2013751.","journal-title":"Ann Neurol"},{"key":"19_CR104","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0921-8734(95)00007-S","volume":"338","author":"AA Morley","year":"1995","unstructured":"Morley AA (1995) The somatic mutation theory of ageing. Mutat Res 338: 19\u201323.","journal-title":"Mutat Res"},{"key":"19_CR105","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJM199503163321104","volume":"332","author":"JA Brennan","year":"1995","unstructured":"Brennan JA, Boyle JO, Koch WM et al. (1995) Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. New Engl J Med 332: 712\u2013717.","journal-title":"New Engl J Med"},{"key":"19_CR106","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1532-5415.1972.tb00787.x","volume":"20","author":"D Harman","year":"1972","unstructured":"Harman D (1972) The biologic clock: the mitochondria? J Am Ger Soc 20: 145\u2013147.","journal-title":"J Am Ger Soc"},{"key":"19_CR107","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/ng1292-324","volume":"2","author":"M Corral-Debrinski","year":"1992","unstructured":"Corral-Debrinski M, Horton T, Lott MT et al. (1992) Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet 2: 324\u2013329.","journal-title":"Nature Genet"},{"key":"19_CR108","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1126\/science.1533953","volume":"256","author":"DC Wallace","year":"1992","unstructured":"Wallace DC (1992) Mitochondrial genetics: a paradigm for aging and degenerative disease? Science 256: 628\u2013632.","journal-title":"Science"},{"key":"19_CR109","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1073\/pnas.89.16.7370","volume":"89","author":"GA Cortopassi","year":"1992","unstructured":"Cortopassi GA, Shibata D, Soong NW et al. (1992) A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA 89: 7370\u20137374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR110","first-page":"1075","volume":"2","author":"NW Soong","year":"1992","unstructured":"Soong NW, Hinton DR, Cortopassi G et al. (1992) Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genet 2: 1075\u20131078.","journal-title":"Nature Genet"},{"key":"19_CR111","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/331717a0","volume":"331","author":"IJ Holt","year":"1988","unstructured":"Holt I.J, Harding AE, Morgan-Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondria) myopathies. Nature 331: 717\u2013719.","journal-title":"Nature"},{"key":"19_CR112","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1126\/science.2711184","volume":"244","author":"EA Schon","year":"1989","unstructured":"Schon EA, Rizzuto R, Moraes CT et al. (1989) A direct repeat is a hotspot for large-scale deletions of human mitochondrial DNA. Science 244: 346\u2013349.","journal-title":"Science"},{"key":"19_CR113","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/nar\/18.3.561","volume":"18","author":"S Mita","year":"1990","unstructured":"Mita S, Rizzuto R, Moraes CT et al. (1990) Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acids Res 18: 561\u2013567.","journal-title":"Nucleic Acids Res"},{"key":"19_CR114","first-page":"418","volume":"46","author":"H Nakase","year":"1990","unstructured":"Nakase H, Moraes CT, Rizzuto R et al. (1990) Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome:implications for pathogenesis. Am J Hum Genet 46: 418\u2013427.","journal-title":"Am J Hum Genet"},{"key":"19_CR115","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0925-4439(92)90059-V","volume":"1180","author":"S Simonetti","year":"1992","unstructured":"Simonetti S, Chen X, DiMauro S et al. (1992) Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochim Biophys Acta 1180: 113\u2013122.","journal-title":"Biochim Biophys Acta"},{"key":"19_CR116","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0891-5849(96)00546-1","volume":"22","author":"CM Lee","year":"1997","unstructured":"Lee CM, Weindruch R, Aiken JM (1997) Age-associated alterations of the mitochondrial genome. Free Rad Biol Med 22: 1259\u20131269.","journal-title":"Free Rad Biol Med"},{"key":"19_CR117","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/(SICI)1098-1004(1997)9:3<265::AID-HUMU8>3.0.CO;2-6","volume":"9","author":"VW Liu","year":"1997","unstructured":"Liu VW, Zhang C, Linnane AW et al. (1997) Quantitative allele-specific PCR: demonstration of age-associated accumulation in human tissues of the A-G mutation at nucleotide 3243 in mitochondrial DNA. Hum Mutat 9: 265\u2013271.","journal-title":"Hum Mutat"},{"key":"19_CR118","first-page":"591","volume":"59","author":"F Pallotti","year":"1996","unstructured":"Pallotti F, Chen X, Bonilla E et al. (1996) Evidence that specific mtDNA point mutations may not accumulate in skeletal muscle during normal human aging. Am J Hum Genet 59: 591\u2013602.","journal-title":"Am J Hum Genet"},{"key":"19_CR119","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0921-8734(95)00021-W","volume":"338","author":"B Kadenbach","year":"1995","unstructured":"Kadenbach B, Munscher C, Frank V et al. (1995) Human aging is associated with stochastic somatic mutations of mitochondrial DNA. Mutat Res 338: 161\u2013172.","journal-title":"Mutat Res"},{"key":"19_CR120","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/qjmed\/89.4.251","volume":"89","author":"EJ Brierly","year":"1996","unstructured":"Brierly EJ, Johnson MA, James OF et al. (1996) Effects of physical activity and age on mitochondrial function. Q J Med 89: 251\u2013258.","journal-title":"Q J Med"},{"key":"19_CR121","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0005-2728(96)00077-1","volume":"1276","author":"S Papa","year":"1996","unstructured":"Papa S (1996) Mitochondria) oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications. Biochim Biophy Acta 1276: 87\u2013105.","journal-title":"Biochim Biophy Acta"},{"key":"19_CR122","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1006\/bbrc.1996.1839","volume":"229","author":"A Barrientos","year":"1996","unstructured":"Barrientos A, Casademont J, Rotig A et al. (1996) Absence of relationship between the level of electron transport chain activities and aging in human skeletal muscle. Biochem Biophys Res Commun 229: 536\u2013539.","journal-title":"Biochem Biophys Res Commun"},{"key":"19_CR123","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0925-4439(95)00027-2","volume":"1271","author":"AW Linnane","year":"1995","unstructured":"Linnane AW, Degli Esposti M, Generowicz M et al. (1995) The universality of bioenergetic disease and amelioration with redox therapy. Biochim Biophys Acta 1271: 191\u2013194.","journal-title":"Biochim Biophys Acta"},{"key":"19_CR124","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1073\/pnas.94.7.3064","volume":"94","author":"TM Hagen","year":"1997","unstructured":"Hagen TM, Yowe DL, Bartholomew JC et al. (1997) Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. Proc Natl Acad Sci USA 94: 3064\u20133069.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR125","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0005-2728(98)00167-4","volume":"1410","author":"WG Talton","year":"1999","unstructured":"Talton WG, Olanow CW (1999) Apoptosis in neurodegenerative diseases: the role of mitochondria. Biochim Biophys Acta 1410; 195\u2013213.","journal-title":"Biochim Biophys Acta"},{"key":"19_CR126","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1084\/jem.185.8.1481","volume":"185","author":"M Leist","year":"1997","unstructured":"Leist M, Single B, Castoldi AF et al. (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185: 1481\u20131486.","journal-title":"J Exp Med"},{"key":"19_CR127","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0005-2728(98)00110-8","volume":"1366","author":"SA Susin","year":"1998","unstructured":"Susin SA, Zamzami N, Kroemer G (1998) Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1366: 151\u2013156.","journal-title":"Biochim Biophys Acta"},{"key":"19_CR128","first-page":"139","volume":"1366","author":"S Schimizu","year":"1999","unstructured":"Shimizu S, Narita M, Tsujimoto Y (1999) Bc1\u20132 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1366: 139\u2013149.","journal-title":"Nature"},{"key":"19_CR129","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0092-8674(00)80085-9","volume":"86","author":"P Liu","year":"1996","unstructured":"Liu P, Kim CN, Yang J et al. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147\u2013157.","journal-title":"Cell"},{"key":"19_CR130","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","volume":"91","author":"P Li","year":"1997","unstructured":"Li P, Nijhawan D, Budihardo I et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-l\/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479\u2013489.","journal-title":"Cell"},{"key":"19_CR131","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1084\/jem.184.4.1331","volume":"184","author":"SA Susin","year":"1996","unstructured":"Susin SA, Zamzami N, Castedo M et al. (1996) Bcl-2 inhibits the mitochondrial release of an apoptotic protease. J Exp Med 184: 1331\u20131341.","journal-title":"J Exp Med"},{"key":"19_CR132","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0959-4388(96)80101-2","volume":"6","author":"DW Choi","year":"1996","unstructured":"Choi DW (1996) Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 6: 667\u2013672.","journal-title":"Curr Opin Neurobiol"},{"key":"19_CR133","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF02110643","volume":"28","author":"P Bernardi","year":"1996","unstructured":"Bernardi P, Petronilli V (1996) The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J Bioenerg Biomembr 28: 131\u2013138.","journal-title":"J Bioenerg Biomembr"},{"key":"19_CR134","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","volume":"96","author":"O Hansson","year":"1999","unstructured":"Hansson O, Petersen A, Leist M et al. (1999) Transgenic mice expressing a Huntington\u2019s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc Natl Acad Sci USA 96: 8727\u20138732.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Advances in Experimental Medicine and Biology","Neuropathology and Genetics of Dementia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-1249-3_19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T11:30:54Z","timestamp":1637580654000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-1249-3_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"ISBN":["9781461354611","9781461512493"],"references-count":134,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-1249-3_19","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2001]]}}}